Purdue in $8.3B opioid deal with US

Purdue Pharma has reached an $8.34 billion settlement with the Justice Department over its aggressive marketing of OxyContin, paving the way for the drugmaker to steer future profits to cities and states that accuse it of stoking an opioid-addiction crisis in America. Because Purdue is bankrupt from settling prior claims related to the drug, it … Continue reading Purdue in $8.3B opioid deal with US